National Headache Foundation Launches Primary Care Migraine Program

Ads

You May Also Like

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2017

TORONTO, ONTARIO--(Marketwired - Oct. 19, 2017) - Revive Therapeutics Ltd. ("Revive" or the "Company") ...

Aeglea BioTherapeutics Appoints Dr. Ivana Magovčević-Liebisch to Board of Directors

AUSTIN, Texas, March 26, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage ...

Chembio Completes Acquisition of Malaysia-based RVR Diagnostics

MEDFORD, N.Y., Jan. 10, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...